(Press-News.org) A new lifecycle study published in IOP Publishing’s journal Sustainability Science and Technology has discovered a promising alternative to plastic sanitary products, potentially leading to far reduced sanitary waste. Sanitary pads made with cornstarch are 17 times more environmentally friendly compared to plastic equivalents.
The high concentration of plastic in disposable products is a direct threat to the environment. An estimated 200,000 tonnes of sanitary products are disposed of every year, and the vast majority of them end up in the ocean.
Key statistics:
Sanitary pads made with cornstarch are 17 times more environmentally friendly compared to plastic equivalents.
Each menstruating person uses approximately 120kg of menstrual products in their lifetime
Sanitary pads are made from 90% plastic, corresponding to about 4 plastic bags
55,000 tonnes of plastic sanitary waste per year ends up in North American bodies of water
Scientists found that, over the course of one year, using a cornstarch derived biodegradable material called polylactic acid (PLA) to create sanitary products reduced environmental impact by 17 times compared to the plastic equivalent. The PLA based pads exhibit lower global warming potential and far reduced toxicity due to the material’s more sustainable manufacturing processes compared to fossil-based plastics.
Even taking into account that the production of PLA contributes to higher land use, the overall renewable sourcing and lower environmental footprint mitigate the environmental impacts, in comparison to disposable plastic products.
Sustainable alternatives to traditional sanitary products remain underused by large companies, as they require commercial quantities to make these high-street products viable and affordable. Cornstarch based products are easily producible and can be scaled so that large companies could use it as an effective and sustainable alternative.
Corn is one of the most widely grown crops in the world and is used for a variety of purposes, including food for humans and livestock, biofuel production, and as a raw material in many industrial products. The global trade of corn involves many countries, making it a significant player in the international trade market and enabling large companies to buy large quantities.
Alice Medeiros de Lima, corresponding author of the study, says: “Research into sustainable sanitary materials has consistently shown that while many alternatives to traditional products exist, the key to widespread adoption lies in ease of production, price and scalability. Given the detrimental effects of plastic based sanitary products on the environment, transitioning to cornstarch- based products can significantly reduce waste and provide a more sustainable solution for the future.”
ENDS
About IOP Publishing
IOP Publishing is a society-owned scientific publisher, delivering impact, recognition and value to the scientific community. Its purpose is to expand the world of physics, offering a portfolio of journals, ebooks, conference proceedings and science news resources globally. IOPP is a member of Purpose-Led Publishing, a coalition of society publishers who pledge to put purpose above profit.
As a wholly owned subsidiary of the Institute of Physics, a not-for-profit society, IOP Publishing supports the Institute’s work to inspire people to develop their knowledge, understanding and enjoyment of physics. Visit ioppublishing.org to learn more.
About the authors
This research was led by Prof. Alice Medeiros Lima from the Department of Chemical Engineering at the Federal University of São Carlos (UFSCar), in collaboration with Prof. Sandra Cristina Dantas from the Federal University of Triângulo Mineiro (UFTM). The study was developed as part of the research line on Sustainable Process Systems Engineering, with a focus on life cycle assessment (LCA) and bio-based alternatives. It involved the contribution of undergraduate students who were actively engaged in research activities and have since progressed to work in major chemical industries in Brazil. The project reflects a shared institutional commitment to advancing sustainable technologies and strengthening academia–industry connections.
END
Cornstarch sanitary pads cheap enough to avoid tonnes of ocean plastics
2025-05-01
ELSE PRESS RELEASES FROM THIS DATE:
Loss of genetic plant diversity is visible from space
2025-05-01
Mountain regions are hotspots of biodiversity and represent some of the most species-rich habitats overall. However, these diverse ecosystems are being rapidly transformed by global change.
Over the past five decades, rising temperatures and changes in land use at high altitudes have encouraged the growth and spread of highly competitive plants such as shrubs and trees – a process known as “mountain greening.” The specialized and often low-growing species of open grassland habitats are being pushed back as a result.
Sideritis, a characteristic ...
Rare cancer synovial sarcoma reduced using plasma-activated medium
2025-05-01
Plasma-activated medium (PAM) shows tumor-fighting effects against the rare form of cancer known as synovial sarcoma, an Osaka Metropolitan University-led research team has found.
The group irradiated a mammalian cell culture medium with non-thermal atmospheric-pressure plasma to produce PAM and conducted in vitro tests using human cells and in vivo tests using mice with this type of soft tissue sarcoma.
Graduate School of Medicine student Hana Yao, Associate Professor Hiromitsu Toyoda, and Professor Hiroaki Nakamura, and Graduate School of Engineering Professor Jun-Seok Oh were part ...
Keck Hospital of USC receives 10th “A” Leapfrog safety grade
2025-05-01
LOS ANGELES — Keck Hospital of USC earned an “A” Hospital Safety Grade from The Leapfrog Group, an independent national nonprofit watchdog focused on patient safety.
This is the 10th “A” grade the hospital has received since 2019.
“The Leapfrog Group is one of the most trusted names in health care, and it is a tremendous achievement to once again receive the highest safety grade possible,” said Marty Sargeant, MBA, CEO of Keck Medical Center of USC, which includes Keck Hospital.
Leapfrog assigns a letter grade to general hospitals across the country ...
Gabapentinoids unlikely to be directly linked to self-harm risk
2025-04-30
Treatment with gabapentinoids - drugs such as gabapentin and pregabalin - is not directly associated with an increased risk of self-harm, finds a UK study published by The BMJ today.
However, rates of self-harm were higher before and shortly after treatment, highlighting the need for close monitoring of patients throughout their treatment journey, say the researchers.
Gabapentinoids are prescribed for conditions such as epilepsy, nerve pain, and anxiety disorders.
Previous studies have raised concerns about ...
No-touch vein harvesting has meaningful benefits for heart bypass patients
2025-04-30
‘No-touch’ vein harvesting significantly reduces the risk of graft failure up to three years after coronary artery bypass surgery compared with conventionally harvested vein grafts, finds a study from China published by The BMJ today.
The no-touch technique also translates into meaningful clinical benefits for patients, such as lower rates of heart attacks and need for repeat revascularisation (a procedure to restore blood flow to blocked veins), say the researchers.
A coronary artery bypass graft (CABG) is a surgical procedure used to improve blood flow and oxygen supply to the heart in patients with coronary heart disease. It involves grafting a healthy ...
Single DNA mutation disrupts key tumour-suppressing pathways, elevating blood cancer risk
2025-04-30
GLOBAL: Australian researchers have discovered that a single mutation in the DNA sequence for a methylation enzyme dysregulates key tumour-suppressing pathways, opening up new avenues for blood cancer treatment.
The findings of this research confirm mutant DNA methyltransferase 3A (DNMT3A) as a potential target for effective blood cancer treatment.
One of the most common DNA mutations found in blood cancers is in the sequence encoding DNMT3A. Between 20 and 25% of adults with acute myeloid leukaemia (AML) have mutant DNMT3A.1 This ...
ChatGPT vs students
2025-04-30
ChatGPT vs students: study reveals who writes better (and it’s not the AI)
AI generated essays don’t yet live up to the efforts of real students - according to new research from the University of East Anglia (UK).
A new study published today compared the work of 145 real students with essays generated by ChatGPT.
While the AI essays were found to be impressively coherent and grammatically sound, they fell short in one crucial area – they lacked a personal touch.
As the line between human and machine writing ...
Semaglutide treats liver disease in two thirds of patients
2025-04-30
Semaglutide effectively treats liver disease in two thirds of patients, new research has found.
Results from the ESSENCE phase 3 clinical trial published today in the New England Journal of Medicine shows treating patients with the substance can halt and even reverse the disease.
The placebo-controlled outcome trial of participants with a life-threatening form of liver disease known as Metabolic dysfunction associated steatohepatitis (MASH) was conducted at 253 clinical sites across 37 countries around the world. This is the first regulatory-level trial showing the benefit ...
Gene therapy restores immune function and extends lives of children with rare immune disorder
2025-04-30
An investigational gene therapy has successfully restored immune function in all nine children treated with the rare and life-threatening immune disorder called severe leukocyte adhesion deficiency-I, or LAD-I, in an international clinical trial co-led by UCLA.
LAD-I is a genetic condition that affects approximately one in a million people in the world. It is caused by mutations in the gene that produces CD18, a protein that enables white blood cells to travel from the bloodstream to infection sites. In the absence of this critical protein, individuals with severe LAD-I — most of whom are diagnosed within ...
VCU-led research highlights semaglutide’s potential for treating fatty liver disease
2025-04-30
EMBARGOED FOR RELEASE
5 PM EDT, APRIL 30
CONTACT: A.J. Hostetler
VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health
Phone: 804-543-8656 (cell)
Email: AJ.Hostetler@vcuhealth.org
VCU-led research highlights semaglutide’s potential for treating fatty liver disease
International study shows drug reverses liver damage in patients.
RICHMOND, Va. (April 30, 2025) – An international study led by the director of Virginia Commonwealth University’s liver institute suggests that the substance in Ozempic and Wegovy can halt and even reverse a common liver disease that affects millions worldwide.
Led by Arun Sanyal, M.D., of the Stravitz-Sanyal Institute ...